Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inspire Medical Systems Inc.

www.inspiresleep.com

Latest From Scancell Ltd.

Pipeline Watch: Phase III Starts In MS, Hyperkalemia And Short Stature

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Research & Development Pipeline Watch

Scancell names development director

Scancell, which develops immunotherapies for the treatment of cancer, has appointed Dr Sally Adams to its board of directors as development director – effective 1 May 2014. Dr Adams has worked as a consultant at Nottingham, UK-based Scancell since 2008. Previously, she was head of neurology and virology at British Biotech, and development director at Neures.

Cancer

In Europe, A Public-Private Effort Could Shed Light On The Tricky Business Of Cancer Vaccines

With EU cash in hand, the GAPVAC consortium aims to develop tailor-made vaccines for patients with the rare but aggressive brain cancer, glioblastoma. The vaccines will be unique to each individual, but hopefully with increased efficacy compared with other therapies, thereby justifying the likely higher cost and complexity of treatment.

BioPharmaceutical Europe

New EU-Funded Consortium Aims To Develop Targeted Cancer Vaccines

A clinical trial is expected to start in the U.S. and Europe in 2014 of an individualized approach to developing a cancer vaccine for glioblastoma patients.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Inspire Medical Systems Inc.
  • Senior Management
  • Tim Herbert, Pres. & CEO
    Richard Buchholz , CFO
    Quan Ni, PhD, VP, Research
    Randy Ban, SVP, Sales & Mktg.
  • Contact Info
  • Inspire Medical Systems Inc.
    Phone: (763) 205-7970
    9700 63rd Ave. N.
    Ste. 200
    Maple Grove, MN 55369
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register